doi: 10.1086/603555.
Kinetics of pertussis immune responses to tetanus-diphtheria-acellular pertussis vaccine in health care personnel: implications for outbreak control
Affiliations
- PMID: 19589084
- DOI: 10.1086/603555
Item in Clipboard
Kinetics of pertussis immune responses to tetanus-diphtheria-acellular pertussis vaccine in health care personnel: implications for outbreak control
Clin Infect Dis.
.
Abstract
We assessed the kinetics of the humoral immune response to pertussis antigens following vaccination of health care personnel with adult tetanus-diphtheria-acellular pertussis vaccine (Tdap). By 2 weeks after vaccination, 88%-94% of subjects demonstrated a booster response. This brisk response of adults to Tdap supports a role for vaccination in pertussis outbreak control.
Comment in
-
Bordetella pertussis booster vaccination for health care personnel immediately following a pertussis outbreak in a hospital?Clin Infect Dis. 2009 Aug 15;49(4):588-90. doi: 10.1086/603556. Clin Infect Dis. 2009. PMID: 19589080 No abstract available.
Similar articles
-
Bordetella pertussis booster vaccination for health care personnel immediately following a pertussis outbreak in a hospital?Clin Infect Dis. 2009 Aug 15;49(4):588-90. doi: 10.1086/603556. Clin Infect Dis. 2009. PMID: 19589080 No abstract available.
-
Immunogenicity of reduced antigen content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine.Vaccine. 2007 Jul 20;25(29):5248-52. doi: 10.1016/j.vaccine.2007.05.012. Epub 2007 Jun 4. Vaccine. 2007. PMID: 17583395 Clinical Trial.
-
A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) vaccine in comparison to a tetanus and diphtheria (Td) vaccine when given as booster vaccinations to healthy adults.Vaccine. 2012 Aug 10;30(37):5464-71. doi: 10.1016/j.vaccine.2012.06.073. Epub 2012 Jul 6. Vaccine. 2012. PMID: 22776216 Clinical Trial.
-
Acellular pertussis vaccine use in risk groups (adolescents, pregnant women, newborns and health care workers): a review of evidences and recommendations.Vaccine. 2012 Jul 27;30(35):5179-90. doi: 10.1016/j.vaccine.2012.06.005. Epub 2012 Jun 15. Vaccine. 2012. PMID: 22709953 Review.
-
Tetanus-diphtheria-acellular pertussis vaccination of adults in the USA.Expert Rev Vaccines. 2008 Jul;7(5):621-34. doi: 10.1586/14760584.7.5.621. Expert Rev Vaccines. 2008. PMID: 18564017 Review.
Cited by
-
The UK approach to COVID-19 vaccination: why was it so different?Drugs Context. 2021 May 25;10:2021-4-5. doi: 10.7573/dic.2021-4-5. eCollection 2021. Drugs Context. 2021. PMID: 34104199 Free PMC article.
-
Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP).MMWR Recomm Rep. 2018 Apr 27;67(2):1-44. doi: 10.15585/mmwr.rr6702a1. MMWR Recomm Rep. 2018. PMID: 29702631 Free PMC article.
-
Robust Humoral and Cellular Immune Responses to Pertussis in Adults After a First Acellular Booster Vaccination.Front Immunol. 2018 Apr 4;9:681. doi: 10.3389/fimmu.2018.00681. eCollection 2018. Front Immunol. 2018. PMID: 29670634 Free PMC article. Clinical Trial.
-
No pain no gain? Adjuvant effects of alum and monophosphoryl lipid A in pertussis and HPV vaccines.Curr Opin Immunol. 2017 Aug;47:17-25. doi: 10.1016/j.coi.2017.06.009. Epub 2017 Jul 17. Curr Opin Immunol. 2017. PMID: 28728074 Free PMC article. Review.
-
Pertussis: Microbiology, Disease, Treatment, and Prevention.Clin Microbiol Rev. 2016 Jul;29(3):449-86. doi: 10.1128/CMR.00083-15. Clin Microbiol Rev. 2016. PMID: 27029594 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
